B7H3 targeted CAR-T (Shanghai Changzheng Hospital)

B7H3靶向CAR-T (上海长征医院)

Report date: 2026/05/09 20:00:18

Base Information

Drug NameB7H3 targeted CAR-T (Shanghai Changzheng Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy > Universal CAR-T
Mechanisms of ActionAnti-CD276
TargetsCD276 antigen
Therapy Area/IndicationsSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesShanghai Changzheng Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Changzheng Hospital
Inactive CompaniesN/A
Active IndicationsSarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A